Biogen Inc (BIIB)
216.14
+1.32
(+0.62%)
USD |
NASDAQ |
May 01, 16:00
216.02
-0.12
(-0.06%)
After-Hours: 17:31
Biogen Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 250.00M |
June 30, 2022 | 500.00M |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 750.00M |
June 30, 2021 | 450.00M |
March 31, 2021 | 600.00M |
December 31, 2020 | 400.00M |
September 30, 2020 | 1.25B |
June 30, 2020 | 2.809B |
March 31, 2020 | 2.220B |
December 31, 2019 | 2.093B |
September 30, 2019 | 717.90M |
June 30, 2019 | 2.402B |
March 31, 2019 | 655.80M |
December 31, 2018 | 1.353B |
September 30, 2018 | 0.00 |
June 30, 2018 | 2.75B |
March 31, 2018 | 250.00M |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 781.80M |
March 31, 2017 | 583.60M |
December 31, 2016 | 651.10M |
September 30, 2016 | 348.90M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 2.002B |
September 30, 2015 | 2.956B |
June 30, 2015 | 42.20M |
March 31, 2015 | |
December 31, 2014 | 526.82M |
September 30, 2014 | 23.08M |
June 30, 2014 | 336.90M |
March 31, 2014 | |
December 31, 2013 | -0.008M |
September 30, 2013 | 359.28M |
June 30, 2013 | 0.00 |
March 31, 2013 | 41.02M |
December 31, 2012 | 21.54M |
September 30, 2012 | 53.22M |
June 30, 2012 | 446.78M |
March 31, 2012 | 463.17M |
December 31, 2011 | 410.87M |
September 30, 2011 | -13.58M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
2.809B
Maximum
Jun 2020
849.51M
Average
500.00M
Median
Jun 2022
Stock Buybacks (Quarterly) Benchmarks
Eli Lilly and Co | 0.00 |
Bristol-Myers Squibb Co | 0.00 |
Gilead Sciences Inc | 124.00M |
AbbVie Inc | 3.00M |
Sage Therapeutics Inc | -- |